Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteoporosis 2Lymphoma 2Leukemia 2Breast Neoplasms 2Vitamin D Deficiency 1Polyps 1Pain 1Ovarian Neoplasms 1Obesity 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1Adenomatous Polyps 1Adenoma 1

Interventions

Zoledronic Acid 3Risedronic Acid 3Denosumab 3Vitamin D 2Letrozole 2Calcium 2Nutrition Assessment 1Ibandronic Acid 1Geritol 1Calcium Carbonate 1Aromatase Inhibitors 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bone Diseases, Metabolic × Calcium Carbonate × Clear all
NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡